未登录

B

Barbara Pavan

University of Ferrara

H指数:33

被引数:3,596

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intranasal delivery of a nanoencapsulated ursodeoxycholic acid-ferulic acid prodrug enables CNS exposure to antioxidant agents

纳米包封的熊去氧胆酸-阿魏酸前药经鼻给药可实现抗氧化剂对中枢神经系统的暴露

Journal of Drug Delivery Science and Technology

IF4.9

2026-04-290

PRE

A new microphysiological platform to study the permeation of neuroactive agents across intestinal and brain barriers

一种新的微生理平台，用于研究神经活性剂穿过肠道和血脑屏障的渗透。

IF8

2026-03-250

OAAI

Nasal Administration of a Nanoemulsion Based on Methyl Ferulate and Eugenol Encapsulated in Chitosan Oleate: Uptake Studies in the Central Nervous System

基于阿魏酸甲酯和丁香油酚的纳米乳鼻部给药：中枢神经系统摄取研究

IF5.5

2025-03-130

OA

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment

IF5.5

2024-08-011

OAAI

Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells

JOURNAL OF FUNCTIONAL FOODS

IF4

2024-08-011

OAAI

Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles

EXPERT OPINION ON DRUG DELIVERY

IF5.4

2023-12-043

PRE

Heterogeneous patterning of blood-brain barrier and adaptive myelination as renewing key in gray and white matter

NEURAL REGENERATION RESEARCH

IF6.7

2023-07-201

OAAI

Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System

IF5.5

2023-05-238

OAAI

Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers

CRYSTAL GROWTH & DESIGN

IF3.4

2022-04-1217

OA

Evaluation of the In Vitro Biocompatibility of PEDOT:Nafion Coatings

IF4.3

2021-08-0815

OAAI

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

IF5.5

2021-07-3025

OAAI

Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration

IF5.5

2021-07-2717

OAAI

Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?

DRUG DISCOVERY TODAY

IF7.5

2020-09-0124

OAAI

Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-05-0160

OAAI

Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration

IF5.5

2019-03-0319

OAAI

The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability

IF5.5

2018-10-2638

OAAI

Retinal pigment epithelial cells as a therapeutic tool and target against retinopathies

DRUG DISCOVERY TODAY

IF7.5

2018-09-0127

OAAI

Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?

IF5.5

2018-03-2628

OAAI

Carbonate substitution in the mineral component of bone: Discriminating the structural changes, simultaneously imposed by carbonate in A and B sites of apatite

JOURNAL OF SOLID STATE CHEMISTRY

IF3.5

2017-11-01228

OAAI

Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs?

DRUG DISCOVERY TODAY

IF7.5

2017-08-0159

OAAI